Biomerica sells 78,750 shares of Polish medical distributor Diagnosis S.A. for $500k
Biomerica is divesting a 6% stake in Diagnosis S.A., a Poland-based medical products company, through a securities purchase agreement with multiple buyers at $6.35 per share. The transaction represents a partial exit from the company's international holdings and generates $500,00
View filing at SEC.gov →